Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies [Hematologic Malignancy]

Conclusion
Baseline TMTV is a strong independent predictor of outcome in FL. In combination with FLIPI2 score, it identifies patients at high risk of early progression. It warrants further validation as a biomarker for development of first-line PET-adapted approaches in FL.

Source: Journal of Clinical Oncology - October 11, 2016 Category: Cancer & Oncology Authors: Meignan, Cottereau, Versari, Chartier, Dupuis, Boussetta, Grassi, Casasnovas, Haioun, Tilly, Tarantino, Dubreuil, Federico, Salles, Luminari, Trotman Tags: Diagnosis & Staging, Nuclear Medicine Hematologic Malignancy Source Type: research